+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

NGS Informatics Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 199 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925133
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Next-generation sequencing informatics is redefining data management and decision-making in healthcare and life sciences, equipping senior leaders with the digital tools necessary for secure, efficient genomic operations. As technology and compliance standards evolve, organizations require robust informatics platforms to maximize research value, streamline diagnostics, and sustain competitiveness.

Market Snapshot: Next-Generation Sequencing Informatics Market

The next-generation sequencing informatics market continues to experience strong momentum, with a valuation of USD 1.69 billion in 2024 and an anticipated increase to USD 1.99 billion by 2025. With a projected compound annual growth rate of 17.84%, the sector is set to reach USD 6.28 billion by 2032. Growth is fueled by ongoing investments from biotechnology, pharmaceutical, and clinical organizations seeking to adopt innovative informatics tools. Market demand is being defined by the need for digital platforms capable of processing high-throughput sequencing data, supporting regulatory compliance, and optimizing operations across global research and clinical environments. Informatics infrastructure is playing a foundational role in modernizing workflows and creating seamless connections among research institutions and care providers worldwide.

Scope & Segmentation of the Next-Generation Sequencing Informatics Market

  • Application Areas: Solutions provide value in oncology research, genetic disorder analysis, infectious disease surveillance, and reproductive health programs. Informatics platforms support diagnostics, tumor profiling, pathogen detection, and prenatal testing for both clinical and research use cases.
  • Component Types: Organizations rely on bioinformatics services, subscription-based platforms, analytics modules, and data visualization tools to manage and interpret diverse, large-scale multi-omics datasets for meaningful insights.
  • End Users: Key stakeholders encompass research institutes, contract research organizations, diagnostic laboratories, hospitals, pharmaceutical companies, and biotech startups. These users depend on informatics systems to enhance data accuracy and facilitate efficient genomic development initiatives.
  • Technology Segmentation: Digital solutions support sequence alignment, genome annotation, and variant analysis functions. Both cloud-based and on-premises models are adopted to meet regulatory and IT framework requirements in multidisciplinary environments.
  • Deployment Models: Public, private, hybrid cloud, and on-premises deployment options offer flexibility for meeting individual organizational needs for data security, risk tolerance, and governance strategies.
  • Workflow Types: Informatics platforms standardize activities beginning with data ingestion and quality control through advanced analytics and decision support, maintaining consistency and efficiency throughout project phases.
  • Regions Covered: The Americas, led by the US and Canada, are at the forefront of technology uptake. Europe, the Middle East, Africa, and Asia-Pacific, including China, India, Japan, South Korea, and Australia, are rapidly expanding their market presence, supported by tailored regional policy actions and operational shifts.
  • Leading Companies Profiled: Solution providers such as Illumina, Thermo Fisher Scientific, QIAGEN, Roche Diagnostics, Agilent Technologies, PerkinElmer, BGI Genomics, Bio-Rad Laboratories, DNAnexus, and Genedata enable responsive workflows and empower multidisciplinary teams.

Key Takeaways for Senior Decision-Makers

  • Sequencing informatics platforms improve data transfer security, support robust project management, and help bridge gaps between research and diagnostics.
  • Modern systems deliver the capability to adapt rapidly to changing compliance policies and business requirements, reducing the risk of disruptions and supporting business continuity.
  • Integrated analytics enable pharmaceutical and clinical teams to boost innovation, expedite research, and maintain productivity within complex scientific pipelines.
  • Standardized informatics fosters interoperability, which simplifies regulatory reporting and reduces administrative complexity for compliance-focused enterprises.
  • Partnering with recognized suppliers sustains data quality, strengthens operational outcomes, and helps organizations manage risks linked to market evolution.
  • A scalable informatics infrastructure is essential for achieving ongoing agility as technology frameworks and regulations continue to shift.

Tariff Impact and Supplier Adaptation

Changes to U.S. tariffs affecting sequencing-related equipment and reagents are adding new levels of complexity to procurement and supply chain management. Organizations are responding by strengthening relationships with domestic suppliers, investing in local manufacturing capabilities, and customizing service offerings to address specific regional requirements. These actions reinforce organizational resilience, control cost pressures, and help minimize risks during regulatory transitions.

Methodology & Data Sources

This market overview is based on direct interviews with senior executives, bioinformatics specialists, and regulatory authorities. Insights were cross-validated using peer-reviewed studies and independent market assessments to form a reliable basis for both strategic and operational recommendations.

Why This Report Matters

  • Senior leaders gain reliable market intelligence to accelerate digital transformation and select optimal platforms for next-generation sequencing initiatives.
  • Procurement and compliance professionals can leverage targeted analysis to bolster their regulatory adherence and streamline routine operations.
  • Comprehensive segmentation and deployment guidance support evidence-based resource allocation and alignment with enterprise priorities.

Conclusion

Next-generation sequencing informatics is enabling new efficiencies in data management and regulatory practice. Adaptive analytics and integrated compliance functionality provide lasting support for quality, resilience, and productivity in complex digital environments.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Adoption of cloud-native platforms for scalable and cost-effective NGS data processing workflows
5.2. Development of AI-driven variant prioritization models to enhance clinical decision support accuracy
5.3. Implementation of federated learning frameworks for cross-institutional genomic data analysis without data movement
5.4. Utilization of blockchain technology to ensure end-to-end integrity and traceability of NGS datasets across labs
5.5. Integration of multi-omics data visualization tools for comprehensive interpretation of NGS results in precision medicine
5.6. Expansion of automated quality control pipelines combining machine learning for real-time error detection in sequencing runs
5.7. Emergence of containerized bioinformatics applications to streamline reproducibility and portability of NGS analyses
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. NGS Informatics Market, by Application
8.1. Cancer Research
8.1.1. Hematologic Cancer
8.1.2. Solid Tumor
8.2. Genetic Disorder Research
8.3. Infectious Disease
8.3.1. Bacterial Genomics
8.3.2. Viral Genomics
8.4. Reproductive Health
8.4.1. Paternity Testing
8.4.2. Prenatal Screening
9. NGS Informatics Market, by Component
9.1. Services
9.1.1. Custom Services
9.1.2. Subscription Services
9.2. Software Tools
9.2.1. Data Management Tools
9.2.2. Sequencing Data Analysis Tools
9.2.3. Visualization Tools
10. NGS Informatics Market, by End User
10.1. Academic and Research Institutes
10.1.1. Private Research Institutes
10.1.2. Public Universities
10.2. Contract Research Organizations
10.2.1. Clinical Cro0s
10.2.2. Preclinical Cro0s
10.3. Healthcare Providers
10.3.1. Diagnostic Laboratories
10.3.2. Hospitals
10.4. Pharmaceutical and Biotechnology Companies
10.4.1. Large Pharmaceutical Companies
10.4.2. Small Biotechnology Companies
11. NGS Informatics Market, by Technology
11.1. Data Analysis
11.1.1. Alignment and Mapping
11.1.2. Annotation and Interpretation
11.1.3. Variant Calling
11.2. Data Management
11.2.1. Electronic Data Capture Systems
11.2.2. Laboratory Information Management Systems
11.3. Data Storage
11.3.1. Cloud Storage
11.3.2. On-Premise Storage
12. NGS Informatics Market, by Deployment Mode
12.1. Cloud
12.1.1. Private Cloud
12.1.2. Public Cloud
12.2. On-Premise
12.2.1. Co-Located Data Center
12.2.2. In-House Data Center
13. NGS Informatics Market, by Workflow Type
13.1. Primary Analysis
13.1.1. Base Calling
13.1.2. Image Processing
13.2. Secondary Analysis
13.2.1. Alignment
13.2.2. Quality Control
13.2.3. Variant Calling
13.3. Tertiary Analysis
13.3.1. Data Mining
13.3.2. Reporting and Visualization
14. NGS Informatics Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. NGS Informatics Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. NGS Informatics Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Illumina, Inc.
17.3.2. Thermo Fisher Scientific Inc.
17.3.3. QIAGEN N.V.
17.3.4. Roche Diagnostics International AG
17.3.5. Agilent Technologies, Inc.
17.3.6. PerkinElmer, Inc.
17.3.7. BGI Genomics Co., Ltd.
17.3.8. Bio-Rad Laboratories, Inc.
17.3.9. DNAnexus, Inc.
17.3.10. Genedata AG

Companies Mentioned

The companies profiled in this NGS Informatics market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Roche Diagnostics International AG
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • DNAnexus, Inc.
  • Genedata AG

Table Information